Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
Tiantian Li, Chuanqi Chu, Leilei Yu, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4678-4678
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 237
The gut-brain vascular axis in neuroinflammation
Sara Carloni, María Rescigno
Seminars in Immunology (2023) Vol. 69, pp. 101802-101802
Open Access | Times Cited: 59
Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Sonia Facchin, Luisa Bertin, Erica Bonazzi, et al.
Life (2024) Vol. 14, Iss. 5, pp. 559-559
Open Access | Times Cited: 51
Bifidobacterium breve HNXY26M4 Attenuates Cognitive Deficits and Neuroinflammation by Regulating the Gut–Brain Axis in APP/PS1 Mice
Guangsu Zhu, Jianxin Zhao, Gang Wang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 11, pp. 4646-4655
Closed Access | Times Cited: 42
Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model
Sonali Valvaikar, Bhupesh Vaidya, Shikha Sharma, et al.
Neurochemistry International (2024) Vol. 174, pp. 105691-105691
Closed Access | Times Cited: 16
Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review
Manuel Reiriz, Ana Isabel Beltrán-Velasco, Víctor Echeverry‐Alzate, et al.
Nutrients (2025) Vol. 17, Iss. 3, pp. 391-391
Open Access | Times Cited: 2
Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis
Chuanqi Chu, Leilei Yu, Yiwen Li, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1737-1737
Open Access | Times Cited: 35
Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity via AMPK/SOD2 Pathway
Zhenchao Xie, Mahui Zhang, Yuqi Luo, et al.
Aging and Disease (2023) Vol. 14, Iss. 6, pp. 2193-2193
Open Access | Times Cited: 34
Associations between gut microbiota and Parkinson disease: A bidirectional Mendelian randomization analysis
Jiang Li, Jinchen Li, Beisha Tang, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 11, pp. 3471-3477
Closed Access | Times Cited: 29
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence
Xiaoyan Liu, Yi Liu, Junlin Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 833-845
Open Access | Times Cited: 29
Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson’s Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs
Chen-Meng Qiao, Wenyan Huang, Yu Zhou, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 238-238
Open Access | Times Cited: 14
Harnessing the Health and Techno-Functional Potential of Lactic Acid Bacteria: A Comprehensive Review
Lamia Ayed, Sana M’hir, Domenico Nuzzolese, et al.
Foods (2024) Vol. 13, Iss. 10, pp. 1538-1538
Open Access | Times Cited: 9
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access | Times Cited: 1
Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic
Wen-Xiang Duan, Fen Wang, Junyi Liu, et al.
Neuroscience Bulletin (2023) Vol. 40, Iss. 4, pp. 500-516
Open Access | Times Cited: 22
STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway
Xiaolei Zhang, Yu Wang, Jia Lv
Neurochemistry International (2024) Vol. 175, pp. 105683-105683
Closed Access | Times Cited: 8
Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson’s Disease: Implications for Gut Microbiota and PGC-1α
Yuxuan Dong, Yueyan Qi, Jinhu Chen, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7534-7548
Open Access | Times Cited: 7
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease
Büşra Aktaş, Belma Aslım, Deniz Ateş
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Gut-first Parkinson’s disease is encoded by gut dysbiome
Mario Muñoz, Emanuel Candeias, Inês Melo-Marques, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Efficacy of Probiotics in Improving Motor Function and Alleviating Constipation in Parkinson’s Disease: A Randomized Controlled Trial
Nasibeh Ghalandari, Farhad Assarzadegan, Seyed Amir Hassan Habibi, et al.
Deleted Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Nonylphenol induces depressive behavior in rats and affects gut microbiota: A dose–dependent effect
Jiani Pan, Dezhi Lu, Leilei Yu, et al.
Environmental Pollution (2024) Vol. 344, pp. 123357-123357
Closed Access | Times Cited: 4
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
Liyan Yao, Yong Yang, Xiaowei Yang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9078-9109
Closed Access | Times Cited: 4
The Brain–Gut–Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects
Rong Li, Zong Miao, Yue Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Convergence of Neuroinflammation, Microbiota, and Parkinson’s Disease: Therapeutic Insights and Prospects
Nerea Domínguez Rojo, Mercedes Blanco Benítez, Ramón Cava, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 4
Enterococcus faecalis Exerts Neuroprotective Effects via the Vagus Nerve in a Mouse Model of Parkinson’s Disease
Xian Shao, Tao Wu, Mengyun Li, et al.
Molecular Neurobiology (2025)
Closed Access
Page 1 - Next Page

Scroll to top